Glucose-Lowering Medication Use in CKD: Analysis of US Medicare Beneficiaries Between 2007 and 2016

This publication has 29 references indexed in Scilit:

• Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
  New England Journal of Medicine, 2015
• State of the art paper Sulfonylureas and their use in clinical practice
  Archives of Medical Science, 2015
• Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes and Moderate-to-Severe Chronic Renal Insufficiency
  Diabetes Care, 2013
• Efficacy and Safety of Sitagliptin in Patients With Type 2 Diabetes and ESRD Receiving Dialysis: A 54-Week Randomized Trial
  American Journal of Kidney Diseases, 2013
• Use of Metformin in Patients with Kidney and Cardiovascular Diseases
  Cardiorenal Medicine, 2011
• 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
  New England Journal of Medicine, 2008
• Microvascular and Macrovascular Complications of Diabetes
  Clinical Diabetes, 2008
• Metformin therapy and clinical uses
  Diabetes & Vascular Disease Research, 2008
• Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus
  Cochrane Database of Systematic Reviews, 2007
• Identifying Persons with Diabetes Using Medicare Claims Data
  American Journal of Medical Quality, 1999